{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:57:07Z","timestamp":1766516227787},"publisher-location":"Boston, MA","reference-count":64,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461357377"},{"type":"electronic","value":"9781461518235"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-1-4615-1823-5_30","type":"book-chapter","created":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T21:10:29Z","timestamp":1330722629000},"page":"673-694","source":"Crossref","is-referenced-by-count":17,"title":["Haemophilus influenzae Type b Conjugate Vaccines"],"prefix":"10.1007","author":[{"given":"Peter J.","family":"Kniskern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Marburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald W.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3476(42)80002-5","volume":"20","author":"HE Alexander","year":"1943","unstructured":"Alexander, H. E., Ellis, C., and Leidy, G., 1943, Treatment of type-specific Haemophilus influenzae infections in infancy and childhood, J. Pediatr. 20:673\u2013698.","journal-title":"J. Pediatr."},{"key":"30_CR2","first-page":"425","volume":"16","author":"HE Alexander","year":"1944","unstructured":"Alexander, H. E., Heidelberger, M., and Leidy, G., 1944, The protective or curative element in type b H. influenzae rabbit serum, Yale J. Biol. Med. 16:425\u2013440.","journal-title":"Yale J. Biol. Med."},{"key":"30_CR3","first-page":"144","volume":"48","author":"G Anderson","year":"1994","unstructured":"Anderson, G., 1994, Progress toward elimination of Haemophilus influenzae type b diseases among infants and children \u2014 1987\u20131993, Morbid. Mortal. Weekly Rep. 48:144\u2013188.","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"30_CR4","unstructured":"Anderson, P. W., and Eby, R., 1990, Immunogenic Conjugates, U.S. Patent No. 4,902,506."},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/infdis\/136.Supplement.S63","volume":"136","author":"PW Anderson","year":"1977","unstructured":"Anderson, P. W., and Smith, D. H., 1977, Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae type b, J. Infect. Dis. 136 (Suppl.):S63\u2013S70.","journal-title":"J. Infect. Dis."},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/IAI.13.2.581-589.1976","volume":"13","author":"PW Anderson","year":"1976","unstructured":"Anderson, P. W., Pitt, J., and Smith, D. H., 1976, Synthesis and release of polyribophosphate by Haemophilus influenzae type b in vitro, Infect. Immun. 13:581\u2013589.","journal-title":"Infect. Immun."},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1093\/infdis\/136.Supplement.S57","volume":"136","author":"P Anderson","year":"1977","unstructured":"Anderson, P., Smith, D. H., Ingram, D. L., Wilkins, J., Wehrle, P. F., and Howie, V. M., 1977, Antibody to polyribophosphate of Haemophilus influenzae type b in infants and children: Effect of immunization with polyribophosphate, J. Infect. Dis. 136 (Suppl):S57\u2013S62.","journal-title":"J. Infect. Dis."},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.142.7.2464","volume":"142","author":"PW Anderson","year":"1989","unstructured":"Anderson, P. W., Pichichero, M. E., Stein, E. C., Porcelli, S., Betts, R. E., Connuck, D. M., Korones, D., Insel, R. A., Zahradnik, J. M, and Eby, R., 1989, Effect of Oligosaccharide chain length, exposed terminal group and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein CRM197, J. Immunol. 142:2464\u20132468.","journal-title":"J. Immunol."},{"key":"30_CR9","first-page":"3","volume":"26","author":"PJ Baker","year":"1975","unstructured":"Baker, P. J., 1975, Homeostatic control of antibody responses: A model based on recognition of cell-associated antibody by regulatory T cells, Transplant. Rev. 26:3\u201320.","journal-title":"Transplant. Rev."},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00006454-199102000-00004","volume":"10","author":"SB Black","year":"1991","unstructured":"Black, S. B., Shinefield, H. R., Fireman, B., Hiatt, R., Polen, M., Vittinghoff, E., and the Northern California Kaiser Permanente Study Center Pediatrics Group, 1991, Efficacy in infancy of Oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children, Pediatr. Infect. Dis. J. 10:97\u2013104.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.40.1.245-256.1983","volume":"40","author":"CY Chu","year":"1983","unstructured":"Chu, C. Y., Schneerson, R., Robbins, J. B., and Rastogi, S. C., 1983, Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates, Infect. Immun. 40:245\u2013256.","journal-title":"Infect. Immun."},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jama.1992.03480050077028","volume":"267","author":"JD Clemens","year":"1992","unstructured":"Clemens, J. D., Ferreccio, C., Levine, M. M, Horowitz, I., Rao, M. R., Eng, M., Edwards, K. M. and Fritzell, B., 1992, Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine to concurrently administered diphtheria-tetanus-pertussis vaccine, J. Am. Med. Assoc. 267:673\u2013678.","journal-title":"J. Am. Med. Assoc."},{"key":"30_CR13","unstructured":"Code of Federal Regulations, 1991, 21CFR 610.13."},{"key":"30_CR14","unstructured":"Code of Federal Regulations, 1991, 21CFR 610.11."},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/0076-6879(89)78030-7","volume":"178","author":"M Colombatti","year":"1989","unstructured":"Colombatti, M., Dell\u2019Arciprete, L., Rappuoli, R., and Tridente, G., 1989, Selective immunotoxins prepared with mutant diphtheria toxins coupled to monoclonal antibodies, Methods Enzymol. 178:404\u2013422.","journal-title":"Methods Enzymol."},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1016\/S0021-9258(19)41257-X","volume":"250","author":"RM Crisel","year":"1975","unstructured":"Crisel, R. M., Baker, R. S., and Dorman, D. E., 1975, Capsular polymer of Haemophilus influenzae type b. I. Structural characterization of the capsular polymer of strain Egan, J. Biol. Chem. 250:4926\u20134930.","journal-title":"J. Biol. Chem."},{"key":"30_CR17","first-page":"291","volume-title":"Development and Clinical Use of Haemophilus b Conjugate Vaccines","author":"RS Daum","year":"1994","unstructured":"Daum, R. S., and Granoff, D. M, 1994, Lessons from the evaluation of immunogenicity, in: Development and Clinical Use of Haemophilus b Conjugate Vaccines (R. Ellis and D. M. Granoff, eds.), Dekker, New York, pp. 291\u2013312."},{"key":"30_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0022-3476(05)80424-X","volume":"120","author":"MD Decker","year":"1992","unstructured":"Decker, M. D., Edwards, K. M., Bradley, R., and Palmer, P., 1992, Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines, J. Pediatr. 120:184\u2013189.","journal-title":"J. Pediatr."},{"key":"30_CR19","first-page":"48","volume-title":"Conjugate Vaccines","author":"WE Dick","year":"1989","unstructured":"Dick, W. E., and Bevrett, M., 1989, Glycoconjucates of bacterial carbohydrate antigens: a survey and consideration of design and preparation factors, Conjugate Vaccines (J. M. Cruise and R. E. Lewis, eds.), Karger, Basel, p. 48."},{"key":"30_CR20","unstructured":"Drug Information for the Health Care Professional, USP DI, Vol. IA, The U.S. Pharmacopeal Convention, Inc. (1992)."},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman, G. L., 1959, Tissue sulfhydryl groups, Arch. Biochem. Biophys. 82:70\u201377.","journal-title":"Arch. Biochem. Biophys."},{"key":"30_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJM199011153232004","volume":"323","author":"J Eskola","year":"1990","unstructured":"Eskola, J., K\u00e4yhty, H., Takala, A. K., Peltola, H., R\u00f6nnberg, P.-R., Kela, E., Pekkanen, E., McVerry, P., and M\u00e4kel\u00e4, P. H., 1990a, A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease, N. Engl. J. Med. 323:1381\u20131387.","journal-title":"N. Engl. J. Med."},{"key":"30_CR23","unstructured":"Eskola, J., Peltola, H., Takala, A., Palmgren, J., and M\u00e4kel\u00e4, P. H., 1990b, Protective efficacy of the Haemophilus influenzae type b conjugate vaccine HbOC in Finnish infants, Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 1990, American Society for Microbiology, Washington, DC (Abstract No. 60)."},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.24.4.273","volume":"24","author":"LD Fothergill","year":"1933","unstructured":"Fothergill, L. D., Le Roy, D., and Wright, J., 1933, Influenzal meningitis: The relation of age incidence to the bactericidal power of blood against the causal organism, J. Immunol. 24:273\u2013284.","journal-title":"J. Immunol."},{"key":"30_CR25","first-page":"435","volume-title":"Development and Clinical Use of Haemophilus b Conjugate Vaccines","author":"CE Frasch","year":"1994","unstructured":"Frasch, C. E., 1994, Regulatory perspectives in vaccine licensure, in: Development and Clinical Use of Haemophilus b Conjugate Vaccines (R. Ellis and D. M. Granoff, eds.), Dekker, New York, pp. 435\u2013453."},{"key":"30_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0022-3476(05)81786-X","volume":"121","author":"B Fritzell","year":"1992","unstructured":"Fritzell, B., and Plotkin, S., 1992, Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine, J. Pediatr. 121:355\u2013362.","journal-title":"J. Pediatr."},{"key":"30_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1084\/jem.54.3.431","volume":"54","author":"WF Goebel","year":"1931","unstructured":"Goebel, W. F., and Avery, O. T., 1931, Chemo-immunological studies on conjugated carbohydrate-protein. V. The immunological specificity of an antigen prepared by combining one capsular Polysaccharide of type 3 pneumococcus with foreign protein, J. Exp. Med. 54:431\u2013437.","journal-title":"J. Exp. Med."},{"key":"30_CR28","unstructured":"Gordon, L. K., 1986, Polysaccharide Endotoxoid Conjugate Vaccines, 1986, U.S. Patent No. 4,619,828."},{"key":"30_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-3476(05)81186-2","volume":"121","author":"DM Granoff","year":"1992","unstructured":"Granoff, D. M., Anderson, E. L., Osterholm, M. T., Holmes, S. J., McHugh, J. E., Belshe, R. B., Medley, F., and Murphy, T. V., 1992, Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants, J. Pediatr. 121:187\u2013194.","journal-title":"J. Pediatr."},{"key":"30_CR30","first-page":"169A","volume":"33","author":"DM Granoff","year":"1993","unstructured":"Granoff, D. M., Holmes, S. J., Belshe, R. B., and Anderson, E. L., 1993, The effect of carrier priming on the anticapsular antibody response to Haemophilus influenzae type b conjugate vaccines, Pediatr. Res. 33 (No.4, Part 2):169A.","journal-title":"Pediatr. Res."},{"key":"30_CR31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1542\/peds.85.4.694","volume":"85","author":"BM Gray","year":"1990","unstructured":"Gray, B. M., 1990, Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate), Pediatrics 85 (Apr. Suppl.):694\u2013697.","journal-title":"Pediatrics"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1080\/10826079308021683","volume":"16","author":"JP Hennessey","year":"1993","unstructured":"Hennessey, J. P., Bednar, B., and Manam, V., 1993, Molecular size analysis of Haemophilus influenzae type b capsular Polysaccharide, J. Liquid Chromatogr. 16:1715\u20131729.","journal-title":"J. Liquid Chromatogr."},{"key":"30_CR33","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1021\/bi00519a001","volume":"20","author":"HJ Jennings","year":"1981","unstructured":"Jennings, H. J., Lugowski, C., and Kasper, D. L., 1981, Conformational aspects critical to the immunospecificity of the type 3 group B streptococcal Polysaccharide, Biochemistry 20:4511\u20134518.","journal-title":"Biochemistry"},{"key":"30_CR34","first-page":"371","volume-title":"Development and Clinical Use of Haemophilus b Conjugate Vaccines","author":"SL Kaplan","year":"1994","unstructured":"Kaplan, S. L., 1994, Pathogenesis and treatment of infants and children, in: Development and Clinical Use of Haemophilus b Conjugate Vaccines (R. Ellis and D. M. Granoff, eds.), Dekker, New York, pp. 371\u2013388."},{"key":"30_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","volume":"147","author":"H K\u00e4yhty","year":"1983","unstructured":"K\u00e4yhty, H., Peltola, H., Karanko, V., and M\u00e4kel\u00e4, P. H., 1983, The protective level of serum antibodies to the capsular Polysaccharide of Haemophilus influenzae type b, J. Infect. Dis. 147:1100\u20131105.","journal-title":"J. Infect. Dis."},{"key":"30_CR36","first-page":"37","volume-title":"Development and Clinical Uses of Haemophilus b Conjugate Vaccines","author":"PJ Kniskern","year":"1994","unstructured":"Kniskern, P. J., and Marburg, S., 1994, Conjugation: Design, chemistry and analysis, in: Development and Clinical Uses of Haemophilus b Conjugate Vaccines (R. W. Ellis and D. M. Granoff, eds.), Dekker, New York, pp. 37\u201369."},{"key":"30_CR37","unstructured":"Kniskern, P. J., Hagopian, A., and Carlo, D. J., 1981, Meningitis Vaccines, U.S. Patent No. 4,307,080."},{"key":"30_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0264-410X(87)90004-1","volume":"5","author":"MR Lifely","year":"1987","unstructured":"Lifely, M. R., Moreno, C., and Lindon, J. C., 1987, An integrated molecular and immunological approach towards a meningococcal group B vaccine, Vaccine 5:11\u201326.","journal-title":"Vaccine"},{"key":"30_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193:265\u2013275.","journal-title":"J. Biol. Chem."},{"key":"30_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0005-2795(68)90196-7","volume":"168","author":"R Mangalo","year":"1968","unstructured":"Mangalo, R., Bizzini, B., Turpin, A., and Raynaud, M., 1968, The molecular weight of tetanus toxin, Biochim. Biophys. Acta 168:583\u2013584.","journal-title":"Biochim. Biophys. Acta"},{"key":"30_CR41","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1021\/ja00277a037","volume":"108","author":"S Marburg","year":"1986","unstructured":"Marburg, S., Jorn, D., Tolman, R. L., Arison, B., McCauley, J., Kniskern, P. J., Hagopian, A., and Vella, P. P., 1986, Bimolecular chemistry of macromolecules \u2014 Synthesis of bacterial Polysaccharide conjugates with Neisseria meningitidis membrane protein, J. Am. Chem. Soc. 108:5282\u20135297.","journal-title":"J. Am. Chem. Soc."},{"key":"30_CR42","unstructured":"Marburg, S., Tolman, R. L., and Kniskern, P. J., 1987, Covalently-Modified Polyanionic Bacterial Polysaccharides, Stable Covalent Conjugates of Such Polysaccharides and Immunogenic Protein with Bigeneric Spacers, and Methods of Preparing Such Polysaccharides and Conjugates and of Confirming Covalency, U.S. Patent No. 4,695,624."},{"key":"30_CR43","unstructured":"Marburg, S., Tolman, R. L., and Kniskern, P. J., 1989, Covalently-Modified Polyanionic Bacterial Polysaccharides, Stable Covalent Conjugates of Such Polysaccharides and Immunogenic Protein with Bigen-eric Spacers, and Methods of Preparing Such Polysaccharides and Conjugates and of Confirming Covalency, U.S., Patent No. 4,882,317."},{"issue":"8","key":"30_CR44","first-page":"144","volume":"2","author":"MMWR","year":"1994","unstructured":"MMWR, 1994, Progress toward elimination of Haemophilus influenza type b disease among infants and children, Morbid. Mortal. Weekly Rep. 2(8): 144\u2013147.","journal-title":"Morbid. Mortal. Weekly Rep."},{"key":"30_CR45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/infdis\/154.6.935","volume":"154","author":"D Musher","year":"1986","unstructured":"Musher, D., Gorlee, A., Murphy, T., Chapman, A., Zahradnik, J., Apicella, M., and Baughn, R., 1986, Immunity to Haemophilus influenzae type b in young adults: Correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination, J. Infect. Dis. 154:935\u2013943.","journal-title":"J. Infect. Dis."},{"key":"30_CR46","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0019-2791(72)90163-2","volume":"9","author":"AM Pappenheimer Jr.","year":"1972","unstructured":"Pappenheimer, A. M., Jr., Uchida, T., and Harper, A. A., 1972, An immunological study of the diphtheria toxin molecule, Immunochemistry 9:891\u2013906.","journal-title":"Immunochemistry"},{"key":"30_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0022-3476(05)80480-9","volume":"118","author":"JC Parke","year":"1991","unstructured":"Parke, J. C., Schneerson, R., Reimer, C., Black, C., Welfare, S., Bryla, D., Levi, L., Pavliakova, D., Cramton, T., Schulz, D., Cadoz, M., and Robbins, J. B., 1991, Clinical and immunologie responses to Haemophilus influenzae type b-tetanus conjugate vaccine in infants injected at 3,5,7, and 18 months of age, J. Pediatr. 118:184\u2013190.","journal-title":"J. Pediatr."},{"key":"30_CR48","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0264-410X(92)90046-M","volume":"10","author":"CCAM Peeters","year":"1992","unstructured":"Peeters, C. C. A. M., Tenbergen-Meekes, A.-M. J., Poolman, J. T. M., Zegers, B. J., and Rijkers, G. T., 1992, Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate is decreased by admixture of high doses of free saccharide, Vaccine 10:833\u2013840.","journal-title":"Vaccine"},{"key":"30_CR49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.60.5.730","volume":"60","author":"H Peltola","year":"1977","unstructured":"Peltola, H., K\u00e4yhty, H., Sivonen, A., and M\u00e4kel\u00e4, P. H., 1977, Haemophilus influenzae type b capsular Polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland, Pediatrics 60:730\u2013737.","journal-title":"Pediatrics"},{"key":"30_CR50","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM198406143102404","volume":"310","author":"H Peltola","year":"1984","unstructured":"Peltola, H., K\u00e4yhty, H., Virtanen, M., and M\u00e4kel\u00e4, P. H., 1984, Prevention of Haemophilus influenzae type b bacteremic infections with the capsular Polysaccharide vaccine, N. Engl. J. Med. 310:1561\u20131566.","journal-title":"N. Engl. J. Med."},{"key":"30_CR51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/0140-6736(92)92117-X","volume":"340","author":"H Peltola","year":"1992","unstructured":"Peltola, H., Kilpi, T., and Anttila, M., 1992, Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines, Lancet 340:592\u2013594.","journal-title":"Lancet"},{"key":"30_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1203\/00006450-197303000-00001","volume":"7","author":"JB Robbins","year":"1973","unstructured":"Robbins, J. B., Parke, J. C., Jr., Schneerson, R., and Whisnant, J. K., 1973, Quantitative measurement of \u201cnatural\u201d and immunization induced Haemophilus influenzae type b capsular Polysaccharide antibodies, Pediatr. Res. 7:103\u2013110.","journal-title":"Pediatr. Res."},{"key":"30_CR53","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJM199106203242503","volume":"324","author":"M Santosham","year":"1991","unstructured":"Santosham, M., Wolff, M., Reid, R., Hohenboken, M., Bateman, M., Goepp, J., Cortese, M., Sack, D., Hill, J., Newcomer, W., Capriotti, L., Smith, J., Owen, M., Gahagan, S., Hu, D., Kling, R., Lukacs, L., Ellis, R. W, Vella, P. P., Calandra, G., Matthews, H., and Ahonkhai, V., 1991, The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b Polysaccharide and Neisseria meningitidis outer-membrane protein complex, N. Engl. J. Med. 324:1767\u20131772.","journal-title":"N. Engl. J. Med."},{"key":"30_CR54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/IAI.52.2.519-528.1986","volume":"52","author":"R Schneerson","year":"1986","unstructured":"Schneerson, R., Robbins, J. B., Parke, J. C., Bell, C., Schlesselman, J. J., Sutton, A., Wang, Z., Schiffman, G., Karpas, A., and Shiloach, J., 1986, Quantitative and qualitative analysis of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharidetetanus toxoid conjugates, Infect. Immun. 52:519\u2013528.","journal-title":"Infect. Immun."},{"key":"30_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF01053772","volume":"6","author":"RC Seid Jr.","year":"1989","unstructured":"Seid, R. C., Jr., Boykins, R. A., Liu, D.-F., Kimbrough, K. W, Hsieh, C.-L., and Eby, R., 1989, Chemical evidence for covalent linkages of a semisynthetic glycoconjugate vaccine for Haemophilus influenzae type b disease, Glycoconjugate J. 6:489\u2013498.","journal-title":"Glycoconjugate J."},{"key":"30_CR56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/IAI.8.2.278-290.1973","volume":"8","author":"AL Smith","year":"1973","unstructured":"Smith, A. L., Smith, D. H., Averill, D. R., Marino, J., and Moxon, E. R., 1973, Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation, Infect. Immun. 8:278\u2013290.","journal-title":"Infect. Immun."},{"key":"30_CR57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4757-2046-4_6","volume-title":"Immunobiology of Proteins and Peptides V. Vaccines","author":"DH Smith","year":"1989","unstructured":"Smith, D. H., Madore, D. V., Eby, R. J., Anderson, P. W, Insel, R. A., and Johnson, C. L., 1989, Haemophilus b oligosaccharide-CRM197 and other haemophilus b conjugate vaccines. A status report, in: Immunobiology of Proteins and Peptides V. Vaccines (M. Z. Atassi, ed.), Plenum Press, New York, pp. 65\u201382."},{"key":"30_CR58","first-page":"231","volume-title":"Development and Clinical Use of Haemophilus b Conjugate Vaccines","author":"CM Vadheim","year":"1994","unstructured":"Vadheim, C. M., and Ward, J. I., 1994, Epidemiology in developed countries, in: Development and Clinical Use of Haemophilus b Conjugate Vaccines (R. Ellis and D. M. Granoff, eds.), Dekker, New York, pp. 231\u2013245."},{"key":"30_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02388078","volume":"58","author":"JEG Dam van","year":"1990","unstructured":"van Dam, J. E. G., Fleer, A., and Snippe, H., 1990, Immogenicity of Streptococcus pneumoniae capsular polysaccharides, Antoine van Leevwenhoek 58:1.","journal-title":"Antoine van Leevwenhoek"},{"key":"30_CR60","first-page":"1","volume-title":"Vaccines: New Approaches to Immunological Problems","author":"PP Vella","year":"1992","unstructured":"Vella, P. P., and Ellis, R. W., 1992, Haemophilus b conjugate vaccines, in: Vaccines: New Approaches to Immunological Problems (R. W. Ellis, ed.), Butterworth-Heinemann, London, pp. 1\u201321."},{"key":"30_CR61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1542\/peds.85.4.668","volume":"85","author":"PP Vella","year":"1990","unstructured":"Vella, P. P., Staub, J. M., Armstrong, J., Dolan, K. T., Rusk, C. M., Szymanski, S., Greer, W. E., Marburg, S., Kniskern, P. J., Schofield, T. L., Tolman, R. L., Hartner, F., Pan, S.-H., Gerety, R. J., and Ellis, R. W., 1990, Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB\u00ae), Pediatrics 85(Apr. Suppl.):668\u2013675.","journal-title":"Pediatrics"},{"key":"30_CR62","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJM199011153232006","volume":"323","author":"J Ward","year":"1990","unstructured":"Ward, J., Brenneman, G., Letson, G. W., Heyward, W. L., and the Alaska H. influenzae Vaccine Study Group, 1990, Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska native infants, N. Engl. J. Med. 323:1393\u20131401.","journal-title":"N. Engl. J. Med."},{"key":"30_CR63","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.169.6.2121","volume":"169","author":"R Wessels","year":"1989","unstructured":"Wessels, R., and Kasper, D. L., 1989, Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral Polysaccharide, J. Exp. Med. 169:2121\u20132131.","journal-title":"J. Exp. Med."},{"key":"30_CR64","unstructured":"WHO Technical Report, 1991, Requirements for Haemophilus influenzae type b Conjugate Vaccines (Requirements for Biological Substances No. 46), No. 814, pp. 15-37."}],"container-title":["Pharmaceutical Biotechnology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1823-5_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T23:26:04Z","timestamp":1713655564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1823-5_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9781461357377","9781461518235"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1823-5_30","relation":{},"ISSN":["1078-0467"],"issn-type":[{"type":"print","value":"1078-0467"}],"subject":[],"published":{"date-parts":[[1995]]}}}